The ability of animal studies to detect serious post marketing adverse events is limited

Regulatory Toxicology and Pharmacology. 12;64(3):345-349. doi: 10.1016/j.yrtph.2012.09.002

https://linkinghub.elsevier.com/retrieve/pii/S027323001200181X